In gastric cancer inhibition of MTDH may decrease the level of β-catenin and inactivate Wnt/β-catenin pathway through reducing phosphorylation of AKT and glycogen synthase kinase (GSK)-3β (Ser 9) [15]. The gene discussed is GSK3B; the disease is gastric cancer.